by Neoteryx, on September 23,2021
September 2021 — According to a preprint article slated for publication in the next issue of the journal Bioanalysis, the COVID-19 pandemic led to a shift in the way blood …
Read Storyby Neoteryx, on August 18,2021
Los Angeles, USA & Beijing, CHINA — The Mitra® microsampling device from US-based Neoteryx is now registered as a Class I in vitro diagnostic (IVD) medical device with the Chinese …
Read Storyby Neoteryx, on August 3,2021
AUGUST 2021 — According to a news item from Peit Kreuzer reporting in Germany for Deutschlandfunk, doping in sports is dominating the headlines as global sports agencies consider new and …
Read Storyby Neoteryx, on July 26,2021
TORRANCE, July 2021 — Medical device company Neoteryx announces that to support its customers in research, clinical trials, laboratory services, and healthcare networks around the world, it is releasing a …
Read Storyby Neoteryx, on July 2,2021
European research groups, pharmaceutical companies, businesses and health organizations work together to develop personalized treatment options for psoriatic arthritis Dublin, July 2, 2021 – Neoteryx joins a consortium of 26 …
Read Story